Search

Displaying results 51 - 60 of 125 in total
  1. Pathway

    Ketobemidone Action Pathway

    smpdb.ca/view/SMP0000690
    Drug action

    Hyperpolarization of neuron is caused by inactivation of calcium channels and activation of potassium channels via facilitated by G-protein. … The binding of ketobemidone acetate will eventually lead to reduced pain because of decreased nerve conduction and release of neurotransmitter.

    Drugs: ATP · Norepinephrine · Dopamine · Potassium cation · Calcium · Ketobemidone
    Enzymes: Sodium channel subunit beta-1, Sodium-dependent serotonin transporter
  2. Pathway

    Nalbuphine Action Pathway

    smpdb.ca/view/SMP0000691
    Drug action

    Nalbuphine (also known as Rubuphine and Nubain) is a competitive antagonist of mu-type and kappa-type opioid receptor in the central nervous system (CNS).

    Drugs: ATP · Norepinephrine · Nalbuphine · Dopamine · Potassium cation · Calcium
    Enzymes: Sodium channel subunit beta-1, Sodium-dependent serotonin transporter
  3. Pathway

    Methadone Action Pathway

    smpdb.ca/view/SMP0000408
    Drug action

    Methadone further acts as an antagonist at the NMDA receptor, reducting calcium influx and neuronal excitability. … G(i) also activates potassium channels and inactivates calcium channels causing the neuron to hyperpolarize.

    Drugs: NADH · ATP · Methadone · Norepinephrine · Dopamine · Potassium cation +3 more
    Enzymes: Sodium channel subunit beta-1, Sodium-dependent serotonin transporter
  4. Pathway

    Lidocaine (Local Anaesthetic) Metabolism Pathway

    smpdb.ca/view/SMP0000620
    Drug metabolism

    Once inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of the voltage-gated sodium channel from the cytoplasmic side. … Lidocaine exerts its local anaesthetic effect by blocking voltage-gated sodium channels in peripheral neurons. Lidocaine diffuses across the neuronal plasma membrane in its uncharged base form.

    Drugs: NADH · Lidocaine · Mesoheme · Formaldehyde
    Enzymes: Sodium channel subunit beta-1, Sodium channel protein type 10 subunit alpha
  5. Pathway

    Alvimopan Action Pathway

    smpdb.ca/view/SMP0000685
    Drug action

    Alvimopan is prescribed to treat patient opioid-induced constipation, a common side effect of opioid therapy. This side effect results in delayed discharge for hospitalized patients following surgery. Alvimopan helps to increase gastroin...

    Drugs: ATP · Norepinephrine · Dopamine · Potassium cation · Calcium · Alvimopan
    Enzymes: Sodium channel subunit beta-1, Sodium-dependent serotonin transporter
  6. Pathway

    Morphine Action Pathway

    smpdb.ca/view/SMP0000406
    Drug action

    G(i) also activates potassium channels and inactivates calcium channels causing the neuron to hyperpolarize. … The end result is decreased nerve conduction and reduced neurotransmitter release, which blocks the perception of pain signals.

    Drugs: ATP · Morphine · Norepinephrine · Dopamine · Potassium cation · Calcium +1 more
    Enzymes: Sodium channel subunit beta-1, Sodium-dependent serotonin transporter
  7. Pathway

    Methamphetamine Dopamine Reuptake Inhibitor Action Pathway

    smpdb.ca/view/SMP0125231
    Drug action

    Methamphetamine activates trace amine receptor 1 which internalizes sodium dependent dopamine transporters as well as reversing of the transporter. … Methamphetamine enters the neuron through sodium-dependent dopamine transporters where it also is a negative modulator for the transporter, preventing dopamine from re-entering the neuron.

    Drugs: Pyridoxal phosphate · Ademetionine · Ascorbic acid · Tyrosine · Tryptophan · Sapropterin +9 more
    Enzymes: Sodium-dependent dopamine transporter, Sodium-dependent serotonin transporter
  8. Pathway

    Lidocaine (Antiarrhythmic) Action Pathway

    smpdb.ca/view/SMP0000328
    Drug action

    Membrane ion pumps, such as the sodium-potassium ATPase and sodium-calcium exchanger (NCX), maintain low intracellular sodium (5 mM) and calcium (100 nM) concentrations and high intracellular potassium … The extra sodium and calcium ions that entered the cell during the action potential are extruded via sodium-potassium ATPases and NCX and intra- and extracellular ion concentrations are restored.

    Drugs: NADH · ATP · Lidocaine · Potassium cation · Calcium · Mesoheme +1 more
    Enzymes: Sodium/calcium exchanger 1, Sodium channel protein type 5 subunit alpha
  9. Pathway

    Dopamine Action Pathway

    smpdb.ca/view/SMP0125137
    Drug action

    In the synapse, dopamine prevents the re-uptake of norepinephrine by inhibiting Sodium-dependent noradrenaline transporter. … Dopamine enters the sympathetic neuron through a sodium-dependent dopamine transporter.. In the neuron, it is catalyzed by Dopamine beta-hydroxylase to synthesize norepinephrine.

    Drugs: Ascorbic acid · ATP · Norepinephrine · Dopamine · Calcium · Pyrroloquinoline Quinone
    Enzymes: Sodium/calcium exchanger 1, Sodium-dependent dopamine transporter
  10. Pathway

    Dopamine Action Pathway

    smpdb.ca/view/SMP0127069
    Physiological

    In the synapse, dopamine prevents the re-uptake of norepinephrine by inhibiting Sodium-dependent noradrenaline transporter. … Dopamine enters the sympathetic neuron through a sodium-dependent dopamine transporter.. In the neuron, it is catalyzed by Dopamine beta-hydroxylase to synthesize norepinephrine.

    Drugs: Ascorbic acid · ATP · Norepinephrine · Dopamine · Calcium · Pyrroloquinoline Quinone
    Enzymes: Sodium/calcium exchanger 1, Sodium-dependent dopamine transporter